Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial to Optimize Tolerability and Explore the Pharmacodynamics of Intranasal LMN-1001

NCT07852208 is registered in ClinicalTrials.gov with Lumen Bioscience, Inc. as lead sponsor.

NCT NCT07852208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial to Optimize Tolerability and Explore the Pharmacodynamics of Intranasal LMN-1001
Lead sponsor
Lumen Bioscience, Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 9, 2026
Completion date
July 24, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral infections